(Q33602936)

28 July 2017

Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer (English)

1 reference

28 July 2017

1 reference

X Gao

1

1 reference

28 July 2017

J Pang

2

1 reference

28 July 2017

L-Y Li

3

1 reference

28 July 2017

W-P Liu

4

1 reference

28 July 2017

J-M Di

5

1 reference

28 July 2017

Q-P Sun

6

1 reference

28 July 2017

Y-Q Fang

7

1 reference

28 July 2017

X-P Liu

8

1 reference

28 July 2017

X-Y Pu

9

1 reference

28 July 2017

D He

10

1 reference

28 July 2017

M-T Li

11

1 reference

28 July 2017

Z-L Su

12

1 reference

28 July 2017

B-Y Li

13

1 reference

28 July 2017

language of work or name

English

0 references

publication date

14 June 2010

1 reference

28 July 2017

1 reference

28 July 2017

29

1 reference

28 July 2017

32

1 reference

28 July 2017

4555-4566

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.213

28 July 2017

0 references

cites work

Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

ETS transcription factors and their emerging roles in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Phosphorylation of collapsin response mediator protein-2 by Rho-kinase. Evidence for two separate signaling pathways for growth cone collapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Angiogenesis as a therapeutic target in malignant gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

High sensitivity mapping of methylated cytosines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Micrometastases or isolated tumor cells and the outcome of breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Structural bases for CRMP function in plexin-dependent semaphorin3A signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

The epigenetic progenitor origin of human cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Mitochondrial proteomic analysis and characterization of the intracellular mechanisms of bis(7)-tacrine in protecting against glutamate-induced excitotoxicity in primary cultured neurons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Identification and characterization of a retinoic acid-regulated human homologue of the unc-33-like phosphoprotein gene (hUlip) from neuroblastoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Current two-dimensional electrophoresis technology for proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Prostatic tissue protein alterations due to delayed time to freezing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

31 March 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Cancer. The metastasis cascade

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Gene expression profiling identifies clinically relevant subtypes of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

MethPrimer: designing primers for methylation PCRs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Structure and promoter analysis of the human unc-33-like phosphoprotein gene. E-box required for maximal expression in neuroblastoma and myoblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Transcription factors control invasion: AP-1 the first among equals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Collapsin response mediator protein-4 regulates F-actin bundling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Combination Analysis of Activator Protein-1 Family Members, Sp1 and an Activator Protein-2 -Related Factor Binding to Different Regions of the Urokinase Receptor Gene in Resected Colorectal Cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Breaking the rules of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Collapsin response mediator protein-1: a novel invasion-suppressor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Metastasis suppressors alter the signal transduction of cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Tumor metastasis: mechanistic insights and clinical challenges

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Effects of DNA methylation on DNA-binding proteins and gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

The cancer epigenome--components and functional correlates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

Differential expression of the semaphorin 3A pathway in prostatic cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

The A2b adenosine receptor protects against vascular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

The human promoter methylome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.213

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.213

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference